Tag Archives: IMS Health

October, 2016

3 October
QuintilesIMS: Merger Creates Leading Global Integrated Information and Technology-Enabled Healthcare Service Provider

DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–Quintiles IMS Holdings, Inc. (NYSE:Q) today announced that it has successfully completed its merger of equals transaction between IMS Health Holdings, Inc. (NYSE:IMS) and Quintiles Transnational Holdings Inc. The merger of IMS Health, a leading global information and technology services company, and Quintiles, …
Share

12 July
Study Finds Low Levels of Adherence & Persistence Remain Barriers to Reducing Costs of Diabetes Complications

PARSIPPANY, N.J.–(BUSINESS WIRE)–Despite improved diagnosis and advances in treatment options for individuals with Type 2 Diabetes, sub-optimal therapy adherence and persistence result in significant economic and societal burden as well as avoidable patient complications in six diverse healthcare systems around the world, according to a new report series issued today …
Share

4 May
IMS Health and Quintiles to Merge in $9 Billion Deal

DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–IMS Health Holdings, Inc. (NYSE:IMS) and Quintiles Transnational Holdings Inc. (NYSE:Q): Broad range of healthcare information, technology and services solutions to drive efficiencies and insights across the entire life sciences product lifecycle, from R&D through commercial execution to real-world patient outcomes. Capabilities to …
Share

29 March
IMS Health Says Surge in Biosimilars to Drive Significant Change in Health System Costs, Patient Access & Competition by 2020

DANBURY, Conn.–(BUSINESS WIRE)–Greater acceptance of biosimilar medicines in a growing number of therapy areas and an active pipeline of 56 new products in clinical development are expected to deliver total savings of as much as $110 billion to health systems across Europe and the U.S. through 2020, according to new …
Share

3 February
IMS Health Study Finds Significant Shifts in Skills for Top IT Roles in Life Sciences

DANBURY, CT, February 2, 2016 – More than 80 percent of leading life sciences companies have created new digital and innovation leadership roles to capitalize on the information technology transformation in healthcare, with nearly half hiring new chief information officers during the past three years, according to new research issued …
Share

18 November
IMS Report Forecasts Global Drug Spend to Rise to $1.4 Trillion in 2020

DANBURY, CT, November 18, 2015 – More than half of the world’s population will live in countries where medicine use will exceed one dose per person per day by 2020, up from 31 percent in 2005, as the “medicine use gap” between developed and pharmerging markets narrows. According to new …
Share

5 May
IMS Reports Global Spending on Cancer Drugs Reaches $100 Billion in 2014

While the share of total medicine spending on oncologics increased only modestly, the total global spending on oncology medicines reached $100 billion in 2014, according to a new report from IMS Institute for Healthcare Informatics. The Global Oncology Trend Report showed that global spending on cancer drugs, including therapeutic treatments …
Share

14 April
Specialty Drugs Drove Significant Increase in US Drug Spending in 2014

Driven by innovative, yet expensive new specialty drugs, US spending on prescription drugs jumped 13 percent to $374 billion in 2014, the largest percentage increase since 2001, according to a new report. The significant increase was primarily due to the introduction of expensive breakthrough drugs, manufacturer price hikes and a …
Share